Hepion Pharmaceuticals, Inc. (HEPA)
OTCMKTS · Delayed Price · Currency is USD
0.0750
-0.0130 (-14.77%)
At close: May 26, 2026
Hepion Pharmaceuticals Employees
Hepion Pharmaceuticals had 2 employees as of December 31, 2025. The number of employees decreased by 20 or -90.91% compared to the previous year.
Employees
2
Change
-20
Growth
-90.91%
Revenue / Employee
n/a
Profits / Employee
-$1,491,377
Market Cap
2.18M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 2 | -20 | -90.91% |
| Dec 31, 2023 | 22 | -3 | -12.00% |
| Dec 31, 2022 | 25 | 5 | 25.00% |
| Dec 31, 2021 | 20 | 7 | 53.85% |
| Dec 31, 2020 | 13 | 1 | 8.33% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| LakeShore Biopharma | 573 |
| Adaptimmune Therapeutics | 506 |
| CASI Pharmaceuticals | 233 |
| Vaccinex | 27 |
| Eloxx Pharmaceuticals | 10 |
| Iterum Therapeutics | 9 |
| AXIM Biotechnologies | 7 |
Hepion Pharmaceuticals News
- 13 days ago - Hepion Pharmaceuticals Quarterly report: Q1 2026 - Filings
- 4 weeks ago - Hepion Pharmaceuticals Proxy statement: Proxy filing - Filings
- 4 weeks ago - Hepion Pharmaceuticals Proxy statement: Proxy filing - Filings
- 2 months ago - Biotech Alert: Searches spiking for these stocks today - TheFly
- 2 months ago - Hepion Pharmaceuticals Annual report: Q4 2025 - Filings
- 3 months ago - Hepion Pharmaceuticals in-licenses ctRNA biomarker assay from Cirna Diagnostics - TheFly
- 3 months ago - Hepion Pharmaceuticals In-Licenses ctRNA Biomarker Assay to Facilitate Early Diagnosis and Surveillance of Hepatocellular Carcinoma - GlobeNewsWire
- 7 months ago - Hepion Pharmaceuticals Quarterly report: Q3 2025 - Filings